Background: FibroTest (FT) is the most frequently used serum fibrosis marker and consists of an algorithm of five fibrosis markers (alfa2-macroglobulin, apolipoproteinA1, haptoglobin, GGT ...
KOCHI: George (name changed), was 55-years-old when he was diagnosed with fatty liver. Since he was a teetotaller, he did not ...
"It provides a simple getaway to investigate liver damage. It channels us to use expensive investigations like fibroscan or MRI preferentially in those people who have acanthosis nigricans vs. those ...
As one in three Indians gets diagnosed with non-alcoholic fatty liver, a look at how lifestyle choices can make a difference.
Hospitals in Oxford have been awarded £1m to fund new research facilities and equipment. The funding from the National ...
Liver health is a public issue that PCPs can address. Non-invasive liver tests should be routine, especially for patients ...
Those at high risk should undergo a liver fibroscan or elastography,” Dr. Mithal added. Men's Health Week: Expert Reveals ...
On October 15, 2024, the list of selected candidates for the oral report of the American Association for the Study of the Liver (AASLD 2024) annual meeting was officially announced online. The ...
10月22日,福瑞股份跌1.28%,成交额5.47亿元,换手率4.32%,总市值142.11亿元。 根据AI大模型测算福瑞股份后市走势。短期趋势看,该股当前无连续增减仓现象,主力趋势不明显。主力轻度控盘。中期趋势方面,下方累积一定获利筹码。近期该股有吸筹现象,但吸筹力度不强。舆情分析来看,4家机构预测目标均价25.22,低于当前价-52.79%。目前市场情绪极度悲观。 1、公司药品复方鳖甲软肝片主 ...
资料显示,内蒙古福瑞医疗科技股份有限公司的主营业务为肝病领域的药品生产与销售、诊断设备研发与销售以及医疗服务相关业务,主要产品为复方鳖甲软肝片、FibroScan系列肝纤维化诊断仪器 ...